Scaffold biomaterials for nano-pathophysiology. 2014

Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: masaya@frontier.kyoto-u.ac.jp.

This review is intended to provide an overview of tissue engineering strategies using scaffold biomaterials to develop a vascularized tissue engineered construct for nano-pathophysiology. Two primary topics are discussed. The first is the biological or synthetic microenvironments that regulate cell behaviors in pathological conditions and tissue regeneration. Second is the use of scaffold biomaterials with angiogenic factors and/or cells to realize vascularized tissue engineered constructs for nano-pathophysiology. These topics are significantly overlapped in terms of three-dimensional (3-D) geometry of cells and blood vessels. Therefore, this review focuses on neovascularization of 3-D scaffold biomaterials induced by angiogenic factors and/or cells. The novel strategy of this approach in nano-pathophysiology is to utilize the vascularized tissue engineered construct as a tissue model to predict the distribution and subsequent therapeutic efficacy of a drug delivery system with different physicochemical and biological properties.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D054457 Tissue Scaffolds Cell growth support structures composed of BIOCOMPATIBLE MATERIALS. They are specially designed solid support matrices for cell attachment in TISSUE ENGINEERING and GUIDED TISSUE REGENERATION uses. Tissue Scaffolding,Scaffold, Tissue,Scaffolding, Tissue,Scaffoldings, Tissue,Scaffolds, Tissue,Tissue Scaffold,Tissue Scaffoldings
D018919 Neovascularization, Physiologic The development of new BLOOD VESSELS during the restoration of BLOOD CIRCULATION during the healing process. Angiogenesis, Physiologic,Angiogenesis, Physiological,Neovascularization, Physiological,Physiologic Angiogenesis,Physiologic Neovascularization,Physiological Angiogenesis,Physiological Neovascularization
D023822 Tissue Engineering Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures. Engineering, Tissue

Related Publications

Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
December 2021, Nanomedicine (London, England),
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
July 2021, Nanomaterials (Basel, Switzerland),
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
July 2014, Advanced drug delivery reviews,
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
January 2014, BioMed research international,
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
July 2014, Advanced drug delivery reviews,
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
May 2016, Journal of controlled release : official journal of the Controlled Release Society,
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
May 2007, Macromolecular bioscience,
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
June 2019, Regenerative engineering and translational medicine,
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
January 2022, Nanomaterials (Basel, Switzerland),
Masaya Yamamoto, and Shahin Rafii, and Sina Y Rabbany
April 2015, Journal of controlled release : official journal of the Controlled Release Society,
Copied contents to your clipboard!